Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kendall's Tau Test01:16

Kendall's Tau Test

1.2K
Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1 indicates...
1.2K
Phosphorylation01:02

Phosphorylation

53.9K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.9K
Peptide Bonds02:43

Peptide Bonds

83.1K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.1K
Cognitive Dissonance01:38

Cognitive Dissonance

37.5K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Aggregates Classification01:29

Aggregates Classification

1.0K
Aggregate classification is generally based on its size, petrographic characteristics, weight, and source. Size classification ranges from coarse to fine aggregates, defined by the size of the particles. Coarse aggregates are particles that do not pass through ASTM sieve No. 4, and aggregates that pass through the sieve are fine aggregates.
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
1.0K
Language and Cognition01:27

Language and Cognition

801
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
801

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Npas4 is involved in synaptic and cognitive function by regulating the transcription of Neuroligin-1 and N-cadherin.

Translational psychiatry·2026
Same author

Microglial CD31 suppresses Aβ clearance and promotes Alzheimer pathology in 5×FAD mice.

Nature communications·2026
Same author

Cell Type-Specific Downregulation of Dnmt3a in Nucleus Accumbens Oligodendrocytes Prevents Myelin Damage and Reduces Susceptibility to Social Stress in Male Mice.

Biomolecules·2026
Same author

Amyloid Precursor Protein Abnormalities Destabilize Membrane Ferroportin: A Novel Mechanism Underlying Early Brain Pathologies and Memory Impairment in Alzheimer's Disease.

International journal of molecular sciences·2026
Same author

A neurotoxic cryptic peptide arising from TDP-43-dependent cryptic splicing of PKN1.

Nature communications·2026
Same author

Downregulation of forkhead box O1 (FOXO1) acetylation ameliorates cognitive dysfunction by inhibiting endoplasmic reticulum stress-regulated neuronal apoptosis in APP/PS1 transgenic mice.

Neuroprotection (Chichester, England)·2025

Related Experiment Video

Updated: Feb 5, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

19.0K

Phosphorylated peptide Tau-pT181 induced tau aggregation and cognitive dysfunction.

Yong Luo1, Gang Wu1, Yi Liu1

  • 1Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Journal of Alzheimer'S Disease : JAD
|February 3, 2026
PubMed
Summary

Phosphorylation of Tau protein at threonine 181 (p-Tau181) directly causes Tau aggregation, leading to synaptic damage, cognitive impairment, and neuronal loss in Alzheimer's disease (AD). This finding supports p-Tau181 as a key diagnostic marker and therapeutic target for AD.

Keywords:
Alzheimer's diseaseTau aggregationTau-pT181phosphorylation

More Related Videos

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.8K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.4K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

19.0K
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.8K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.4K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Phosphorylation of Tau protein at threonine 181 (p-Tau181) is a critical biomarker for Alzheimer's disease (AD) detection.
  • The precise mechanisms linking Tau phosphorylation at Thr181 to Tau aggregation and neuropathology are not fully understood.

Purpose of the Study:

  • To investigate the impact of the phosphorylated Tau peptide at Thr181 (Tau-pT181) on Tau aggregation, synaptic function, and cognitive abilities.
  • To elucidate the role of Tau-pT181 in neuropathological changes associated with AD.

Main Methods:

  • Synthesis of Tau-pT181 and non-phosphorylated Tau peptide (Tau-nT181).
  • Assessment of Tau aggregation using Thioflavin S assay and in cell models (293/tau cells).
  • Evaluation of synaptic protein levels in primary hippocampal neurons and cognitive function in rats following peptide injection.
  • Transcriptome analysis of iPSC-derived neurons treated with Tau-pT181/Tau-nT181.

Main Results:

  • Tau-pT181 significantly promoted R3 peptide aggregation, unlike Tau-nT181.
  • Tau-pT181 induced Tau aggregation in 293/tau cells and reduced synapse-associated proteins in neurons.
  • Intracerebral injection of Tau-pT181 in rats led to endogenous Tau aggregation, synaptic damage, neuronal loss, and significant cognitive impairment.
  • Transcriptome analysis revealed Tau-pT181 impacts axonogenesis, neuronal development, and Wnt signaling.

Conclusions:

  • This study provides the first direct evidence that Tau phosphorylation at Thr181 drives Tau aggregation.
  • Tau-pT181 directly causes neuropathological alterations and cognitive deficits, establishing its role in AD pathogenesis.
  • The findings support the Tau Thr181 phosphorylation site as a crucial diagnostic marker and potential therapeutic target for AD.